Menu
Qida Biomedical Co., Ltd. logo

Qida Biomedical Co., Ltd.

Free member Since 2021

Taiwan, Taiwan

Qida Biomedical Co., Ltd. Main Image

Taiwan supplier of Veterinary Antibacterial Products, Dog, Cat. Amber-Pet is a company that focuses on the development of pet medicines. It provides medical-related supplies that are both friendly and effective for pets. This is the direction of our care and research. Amber-Pet uses the medical material...

Amber-Pet is a company that focuses on the development of pet medicines. It provides medical-related supplies that are both friendly and effective for pets. This is the direction of our care and research.

Amber-Pet uses the medical material technology of ALISA Bioscience of the United States as the core, and integrates the feedback of the industry's veterinarians, so that our products can be accurately developed according to the needs of users, and continue to introduce new innovations and provide more suitable innovative technology products.

We also provide OEM/ODM and other related services. We welcome distributors/brands who are interested in our research and development and have the same philosophy to cooperate with us.

Our Products

S-BOOST Antibacterial / Antifungal Gel S-BOOST Antibacterial / Antifungal Gel
1/2
AA Formula PowerBlock/ Invisible Liquid Bandage
AA Formula PowerBlock/ Invisible Liquid Bandage
1/2
Ez Stop / Styptic Sticking Paste
Ez Stop / Styptic Sticking Paste
1/2

Company Profile

Membership:
On ECPlaza since 2021
Business Type: Manufacturer, Exporter
Location: Taiwan, Taiwan
Product Category: Veterinary Medicine
Main Item / Product: Veterinary antibacterial products
Keywords: Veterinary Antibacterial Products, Dog, Cat
Main Markets:
  • North America 30%
  • East Asia 30%
  • Domestic Market 30%
Safety / Quality Approvals: SGS
Representative / CEO's Name: Wen-Lin Hsu
Year Established: 2020
Employees Total: 1 to 9
Annual Revenue: Less than US$10,000
Annual Export Rate: 50%
Send your message to this supplier
Wen-Lin Hsu ( Qida Biomedical Co., Ltd. )
(20~4000 Characters)